
Elizabeth Kemmerer
Examiner (ID: 7452, Phone: (571)272-0874 , Office: P/1646 )
| Most Active Art Unit | 1646 |
| Art Unit(s) | 1804, 1616, 1674, 1801, 1646, 1812 |
| Total Applications | 1810 |
| Issued Applications | 1112 |
| Pending Applications | 139 |
| Abandoned Applications | 581 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12637452
[patent_doc_number] => 20180104314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => STABILIZED COMPOSITIONS OF PROTEINS HAVING A FREE THIOL MOIETY
[patent_app_type] => utility
[patent_app_number] => 15/606273
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606273
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/606273 | STABILIZED COMPOSITIONS OF PROTEINS HAVING A FREE THIOL MOIETY | May 25, 2017 | Abandoned |
Array
(
[id] => 11956379
[patent_doc_number] => 20170260529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING'
[patent_app_type] => utility
[patent_app_number] => 15/603777
[patent_app_country] => US
[patent_app_date] => 2017-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 38156
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15603777
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/603777 | POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING | May 23, 2017 | Abandoned |
Array
(
[id] => 12637050
[patent_doc_number] => 20180104180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => THERMO-SENSITIVE BONE GROWTH COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/602941
[patent_app_country] => US
[patent_app_date] => 2017-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15602941
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/602941 | THERMO-SENSITIVE BONE GROWTH COMPOSITIONS | May 22, 2017 | Abandoned |
Array
(
[id] => 12022294
[patent_doc_number] => 20170312392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'Tissue Engineering Methods and Compositions'
[patent_app_type] => utility
[patent_app_number] => 15/596623
[patent_app_country] => US
[patent_app_date] => 2017-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 26229
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15596623
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/596623 | Tissue Engineering Methods and Compositions | May 15, 2017 | Abandoned |
Array
(
[id] => 12728785
[patent_doc_number] => 20180134762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => OSTEOGENIC PROTEINS
[patent_app_type] => utility
[patent_app_number] => 15/587708
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15587708
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/587708 | Osteogenic proteins | May 4, 2017 | Issued |
Array
(
[id] => 14519131
[patent_doc_number] => 10336812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => GDF15 fusion proteins and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/586463
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 27090
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586463
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/586463 | GDF15 fusion proteins and uses thereof | May 3, 2017 | Issued |
Array
(
[id] => 17556090
[patent_doc_number] => 11312766
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => Antibodies against growth differentiation factor 15 and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/096579
[patent_app_country] => US
[patent_app_date] => 2017-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 49322
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 285
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096579
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096579 | Antibodies against growth differentiation factor 15 and uses thereof | Apr 25, 2017 | Issued |
Array
(
[id] => 16979027
[patent_doc_number] => 20210223264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => DIAGNOSTIC METHOD(S) FOR DETECTING AND TREATING POST-INFARCT MYOCARDIUM REMODELING AND DIFFUSE MYOCARDIAL FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/096696
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096696
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096696 | DIAGNOSTIC METHOD(S) FOR DETECTING AND TREATING POST-INFARCT MYOCARDIUM REMODELING AND DIFFUSE MYOCARDIAL FIBROSIS | Apr 24, 2017 | Abandoned |
Array
(
[id] => 11977607
[patent_doc_number] => 20170281761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'METHOD OF TREATING ALVELOR BONE LOSS THROUGH THE USE OF ANTI-SCLEROSTIN ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 15/494121
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 23114
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15494121
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/494121 | Method of treating alvelor bone loss through the use of anti-sclerostin antibodies | Apr 20, 2017 | Issued |
Array
(
[id] => 12239938
[patent_doc_number] => 20180072801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION'
[patent_app_type] => utility
[patent_app_number] => 15/492782
[patent_app_country] => US
[patent_app_date] => 2017-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 34263
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15492782
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/492782 | ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION | Apr 19, 2017 | Abandoned |
Array
(
[id] => 12001872
[patent_doc_number] => 20170306027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'ALK7 ANTAGONISTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/480726
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 73162
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480726
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/480726 | ALK7 ANTAGONISTS AND USES THEREOF | Apr 5, 2017 | Abandoned |
Array
(
[id] => 12584931
[patent_doc_number] => 20180086806
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2018-03-29
[patent_title] => BMPRII POLYPEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/480275
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480275
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/480275 | BMPRII POLYPEPTIDES AND USES THEREOF | Apr 4, 2017 | Abandoned |
Array
(
[id] => 12584931
[patent_doc_number] => 20180086806
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2018-03-29
[patent_title] => BMPRII POLYPEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/480275
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480275
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/480275 | BMPRII POLYPEPTIDES AND USES THEREOF | Apr 4, 2017 | Abandoned |
Array
(
[id] => 16389518
[patent_doc_number] => 20200330459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED CARDIOMETABOLIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/089842
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089842
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089842 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED CARDIOMETABOLIC DISEASES | Apr 4, 2017 | Abandoned |
Array
(
[id] => 11756055
[patent_doc_number] => 20170202922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'TARGETED CARGO PROTEIN COMBINATION THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/473446
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19193
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15473446
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/473446 | TARGETED CARGO PROTEIN COMBINATION THERAPY | Mar 28, 2017 | Abandoned |
Array
(
[id] => 11729312
[patent_doc_number] => 20170190756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'RECOMBINANT NEL-LIKE (NELL) PROTEIN PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 15/462682
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 17478
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15462682
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/462682 | RECOMBINANT NEL-LIKE (NELL) PROTEIN PRODUCTION | Mar 16, 2017 | Abandoned |
Array
(
[id] => 11713661
[patent_doc_number] => 20170182160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'METHODS OF TREATING ATOPIC DERMATITIS WITH IL-31 MONOCLONAL ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 15/455278
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 37969
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15455278
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/455278 | Methods of treating atopic dermatitis with IL-31 monoclonal antibodies | Mar 9, 2017 | Issued |
Array
(
[id] => 12001877
[patent_doc_number] => 20170306031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'BINDING PROTEINS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/449839
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 98
[patent_figures_cnt] => 98
[patent_no_of_words] => 100242
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449839
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449839 | Binding proteins and methods of use thereof | Mar 2, 2017 | Issued |
Array
(
[id] => 14145467
[patent_doc_number] => 10253092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => Medicament and apparatus for treating chronic kidney disease
[patent_app_type] => utility
[patent_app_number] => 15/436139
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 5919
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15436139
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/436139 | Medicament and apparatus for treating chronic kidney disease | Feb 16, 2017 | Issued |
Array
(
[id] => 11943288
[patent_doc_number] => 20170247439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'METHODS FOR TREATING OSTEOGENESIS IMPERFECTA'
[patent_app_type] => utility
[patent_app_number] => 15/427920
[patent_app_country] => US
[patent_app_date] => 2017-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 20996
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427920
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/427920 | Methods for treating osteogenesis imperfecta | Feb 7, 2017 | Issued |